EBITDA: Income before interest, taxes, depreciation and amortization.
Imunon, Inc. (IMNN) had EBITDA of $-2.60M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.74M |
|
-- |
|
-- |
|
$2.77M |
|
$-2.77M |
|
$0.03M |
|
$-2.74M |
|
$-2.74M |
|
$-2.74M |
|
$-2.74M |
|
$-2.74M |
|
$-2.74M |
|
$-2.77M |
|
|
EBITDA |
$-2.60M |
1.47M |
|
1.47M |
|
$-1.87 |
|
$-1.87 |
|
| Balance Sheet Financials | |
$6.89M |
|
$0.68M |
|
$1.90M |
|
$8.79M |
|
$5.32M |
|
-- |
|
$0.81M |
|
$6.13M |
|
$2.66M |
|
$2.66M |
|
$2.66M |
|
1.98M |
|
| Cash Flow Statement Financials | |
$-5.80M |
|
$-0.28M |
|
$4.93M |
|
$5.87M |
|
$4.73M |
|
$-1.14M |
|
$0.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-103.03% |
|
-103.03% |
|
-31.18% |
|
-103.03% |
|
$1.35 |
|
$-4.14 |
|
$-3.95 |
|